{"ModuleTitle": "Company Description", "CompanyName": "Fluidigm Corporation", "Symbol": "FLDM", "Address": "7000 SHORELINE COURT SUITE 100, SOUTH SAN FRANCISCO, California, 94080, United States of America", "Phone": "6502666000", "Industry": "Biotechnology: Laboratory Analytical Instruments", "Sector": "Capital Goods", "Region": "North America", "CompanyDescription": "Fluidigm is a global company that improves life through comprehensive health\r\ninsight. Our innovative patented technologies and multi-omic tools are used by\r\nresearchers to reveal meaningful insights into health and disease, identify\r\nbiomarkers to inform decisions, and accelerate the development of more effective\r\ntherapies. We create, manufacture, and market a range of products and services,\r\nincluding instruments, reagents and software that are used by researchers\r\nworldwide.\r\nOur focus is on the most pressing needs in translational and clinical research,\r\nincluding cancer, immunology and immunotherapy. We use proprietary CyTOF\u00ae and\r\nmicrofluidics technologies to develop innovative end-to-end solutions that have\r\nthe flexibility required to meet the needs of translational research and the\r\nrobustness to support high-impact clinical research studies.\r\nOur mass cytometry Helios(TM) system deeply profiles cell phenotype and function.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f27%2f0001162194-20-000016.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andrew Quong", "title": "Chief Science Officer"}, {"name": "Bradley Kreger", "title": "Senior Vice President-Global Operations"}, {"name": "David A. King", "title": "Vice President-Research & Development"}, {"name": "Stephen Christopher Linthwaite", "title": "President, Chief Executive Officer & Director"}, {"name": "Vikram Jog", "title": "Chief Financial Officer"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}